- Home
- AMBC vs AUTL Comparison
AMBC vs AUTL Comparison
Compare AMBC & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- AUTL
- Stock Information
- Founded
- AMBC 1991
- AUTL 2014
- Country
- AMBC United States
- AUTL United Kingdom
- Employees
- AMBC N/A
- AUTL N/A
- Industry
- AMBC Property-Casualty Insurers
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMBC Finance
- AUTL Health Care
- Exchange
- AMBC Nasdaq
- AUTL Nasdaq
- Market Cap
- AMBC 635.7M
- AUTL 609.4M
- IPO Year
- AMBC 1991
- AUTL 2018
- Fundamental
- Price
- AMBC $11.05
- AUTL $2.30
- Analyst Decision
- AMBC Strong Buy
- AUTL Strong Buy
- Analyst Count
- AMBC 2
- AUTL 3
- Target Price
- AMBC $17.00
- AUTL $10.20
- AVG Volume (30 Days)
- AMBC 664.0K
- AUTL 1.6M
- Earning Date
- AMBC 02-25-2025
- AUTL 11-12-2024
- Dividend Yield
- AMBC N/A
- AUTL N/A
- EPS Growth
- AMBC N/A
- AUTL N/A
- EPS
- AMBC N/A
- AUTL N/A
- Revenue
- AMBC $398,000,000.00
- AUTL $10,091,000.00
- Revenue This Year
- AMBC N/A
- AUTL $851.83
- Revenue Next Year
- AMBC N/A
- AUTL $264.18
- P/E Ratio
- AMBC N/A
- AUTL N/A
- Revenue Growth
- AMBC 22.46
- AUTL 82.71
- 52 Week Low
- AMBC $10.12
- AUTL $2.07
- 52 Week High
- AMBC $18.45
- AUTL $7.37
- Technical
- Relative Strength Index (RSI)
- AMBC 31.62
- AUTL 38.43
- Support Level
- AMBC $10.67
- AUTL $2.17
- Resistance Level
- AMBC $12.84
- AUTL $2.80
- Average True Range (ATR)
- AMBC 0.42
- AUTL 0.17
- MACD
- AMBC -0.18
- AUTL 0.04
- Stochastic Oscillator
- AMBC 17.51
- AUTL 31.51
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. The business operations of the company include Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. The Company has three reportable segments namely Legacy Financial Guarantee Insurance, Specialty Property and Casualty Insurance and Insurance Distribution. Majority of revenues are earned from Legacy Financial Guarantee Insurance segment.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.